Beers Criteria - Auxiliary Tables
American Geriatrics Society 2023 updated AGS Beers Criteria® - Auxiliary TablesReference
(Press 'Ctrl-F' to search for a particular drug.)
CNS Active Drug List [Table 5 supplement]
Avoid concurrent use of ≥3 CNS-active drugs; minimize the number of CNS-active drugs.
Drug Drug Type(s)   Drug Drug Type(s)
acetaminophen-codeine Opioids   lamoTRIgine Antiepilepticsa
acetaminophen-HYDROcodone Opioids   levETIRAcetam Antiepilepticsa
acetaminophen-oxyCODONE Opioids   levomilnacipran Antidepressants (SNRIs)
acetaminophen-traMADol Opioids   LORazepam Antiepilepticsa, Benzodiazepines
ALPRAZolam Benzodiazepines   loxapine Antipsychotics1
amitriptyline Antidepressants (TCAs)   lurasidone Antipsychotics2
ARIPiprazole Antipsychotics2   meperidine Opioids
asenapine Antipsychotics2   metaxalone Skeletal muscle relaxants
baclofen Skeletal muscle relaxants   methadone Opioids
brexpiprazole Antipsychotics2   methocarbamol Skeletal muscle relaxants
brivaracetam Antiepilepticsa   midazolam Antiepilepticsa, Benzodiazepines
cannabidiol Antiepilepticsa   milnacipran Antidepressants (SNRIs)
carBAMazepine Antiepilepticsa   morphine Opioids
cariprazine Antipsychotics2   nortriptyline Antidepressants (TCAs)
carisoprodol Skeletal muscle relaxants   OLANZapine Antipsychotics2
cenobamate Antiepilepticsa   orphenadrine Skeletal muscle relaxants
chlordiazePOXIDE Benzodiazepines   oxazepam Benzodiazepines
chlorproMAZINE Antipsychotics1   OXcarbazepine Antiepilepticsa
chlorzoxazone Skeletal muscle relaxants   oxyCODONE Opioids
citalopram Antidepressants (SSRIs)   oxyMORphone Opioids
cloBAZam Antiepilepticsa, Benzodiazepines   paliperidone Antipsychotics2
clomiPRAMINE Antidepressants (TCAs)   PARoxetine Antidepressants (SSRIs)
clonazePAM Antiepilepticsa, Benzodiazepines   perampanel Antiepilepticsa
clorazepate Benzodiazepines   perphenazine Antipsychotics1
cloZAPine Antipsychotics2   PHENobarbital Antiepilepticsa
codeine Opioids   phenytoin Antiepilepticsa
cyclobenzaprine Skeletal muscle relaxants   pimavanserin Antipsychotics2
dantrolene Skeletal muscle relaxants   pimozide Antipsychotics1
desipramine Antidepressants (TCAs)   pregabalin Antiepilepticsa
desvenlafaxine Antidepressants (SNRIs)   primidone Antiepilepticsa
diazePAM Antiepilepticsa, Benzodiazepines,
Skeletal muscle relaxants
  prochlorperazine Antipsychotics1
divalproex sodium Antiepilepticsa   QUEtiapine Antipsychotics2
doxepin Antidepressants (TCAs)   risperiDONE Antipsychotics2
droperidol Antipsychotics1   rufinamide Antiepilepticsa
DULoxetine Antidepressants (SNRIs)   sertraline Antidepressants (SSRIs)
escitalopram Antidepressants (SSRIs)   stiripentol Antiepilepticsa
eslicarbazepine Antiepilepticsa   SUFentanil Opioids
estazolam Benzodiazepines   temazepam Benzodiazepines
eszopiclone "Z-drugs"b   thioridazine Antipsychotics1
ethosuximide Antiepilepticsa   thiothixine Antipsychotics1
everolimus Antiepilepticsa   tiaGABine Antiepilepticsa
felbamate Antiepilepticsa   tiZANidine Skeletal muscle relaxants
fenfluramine Antiepilepticsa   topiramate Antiepilepticsa
fentaNYL Opioids   traMADol Opioids
FLUoxetine Antidepressants (SSRIs)   triazolam Benzodiazepines
fluPHENAZine Antipsychotics1   trifluoperazine Antipsychotics1
fLuvoxaMINE Antidepressants (SSRIs)   valproic acid Antiepilepticsa
gabapentin Antiepilepticsa   venlafaxine Antidepressants (SNRIs)
ganaxolone Antiepilepticsa   vigabatrin Antiepilepticsa
haloperidol Antipsychotics1   zaleplon "Z-drugs"b
HYDROmorphone Opioids   ziprasidone Antipsychotics2
iloperidone Antipsychotics2   zolpidem "Z-drugs"b
imipramine Antidepressants (TCAs)   zonisamide Antiepilepticsa
lacosamide Antiepilepticsa  
Footnotes:
a including gabapentinoids
b Nonbenzodiazepine benzodiazepine receptor agonist hypnotics
1 1st Generation Antipsychotics
2 2nd Generation Antipsychotics
Drugs with strong anticholinergic properties. [Table 7]
Note: This table is not a comprehensive list of all medications with anticholinergic properties.
Drug Drug Type   Drug Drug Type
amitriptyline Antidepressants   homatropine Antispasmodics
amoxapine Antidepressants   hydrOXYzine Antihistamines (1st-generation)
atropine Antispasmodics   hyoscyamine Antispasmodics
benztropine Antiparkinsonian agents   imipramine Antidepressants
brompheniramine Antihistamines (1st generation)   meclizine Antihistamines (1st generation)
chlorpheniramine Antihistamines (1st generation)   nortriptyline Antidepressants
chlorproMAZINE Antipsychotics   OLANZapine Antipsychotics
clidinium-chlordiazePOXIDE Antispasmodics   orphenadrine Skeletal muscle relaxants
clomiPRAMINE Antidepressants   oxybutynin Antimuscarinicsa
cloZAPine Antipsychotics   PARoxetine Antidepressants
cyclobenzaprine Skeletal muscle relaxants   perphenazine Antipsychotics
cyproheptadine Antihistamines (1st generation)   prochlorperazine Antiemetics
darifenacin Antimuscarinicsa   promethazine Antiemetics
desipramine Antidepressants   promethazine Antihistamines (1st generation)
dicyclomine Antispasmodics   scopolamine Antispasmodics
dimenhyDRINATE Antihistamines (1st generation)   solifenacin Antimuscarinicsa
diphenhydrAMINE Antihistamines (1st generation)   tolterodine Antimuscarinicsa
doxepin (>6 mg/day) Antidepressants   trihexyphenidyl Antiparkinsonian agents
doxylamine Antihistamines (1st generation)   triprolidine Antihistamines (1st generation)
fesoterodine Antimuscarinicsa   trospium Antimuscarinicsa
flavoxATE Antimuscarinicsa  
Footnotes:
a Antimuscarinics (for urinary incontinence): Data on whether certain bladder antimuscarinics confer greater adverse cognitive effects than others lack consistent quality. oxybutynin has the best evidence for adverse cognitive effects. However, caution is warranted for all bladder antimuscarinics given their potential anticholinergic effects.
Principles for how patients, clinicians, health systems, and payors should use the AGS Beers Criteria®. [Table 11]
TABLE 11 Principles for how patients, clinicians, health systems, and payors should use the AGS Beers Criteria®.
• Medications in the AGS Beers Criteria® are potentially inappropriate, not definitely inappropriate.
• Read the rationale and recommendations statements for each criterion. The caveats and guidance listed there are important.
• Understand why medications are included in the AGS Beers Criteria® and adjust your approach to those medications accordingly.
• Optimal application of the AGS Beers Criteria® involves identifying PIMs and, when appropriate, offering safer nonpharmacologic and pharmacologic therapies.
• The AGS Beers Criteria® should be a starting point for a comprehensive process of identifying and improving medication appropriateness and safety.
• Access to medications included in the AGS Beers Criteria® should not be excessively restricted by prior authorization and/or health plan coverage policies.
• The AGS Beers Criteria® are not equally applicable to all countries (because of cross-national differences in drug availability).

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.